| Stephen E Buckley, MD | |
|
100 Methodist Hospital Blvd, Hattiesburg, MS 39402-1295 | |
| (601) 268-5185 | |
| (601) 268-5006 |
| Full Name | Stephen E Buckley |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 34 Years |
| Location | 100 Methodist Hospital Blvd, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740283126 | NPI | - | NPPES |
| 00011825 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 12824 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Merit Health Wesley | Hattiesburg, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastrointestinal Associates Pa | 5294795241 | 90 |
News Archive
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on December 29, 2009, it received a written notice from the listing qualifications staff of the NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on January 4, 2010 and that NASDAQ would initiate procedures to delist the Company's common stock.
The HHS Office of the Assistant Secretary for Preparedness and Response is trying to harness the power of social media to respond to public health emergencies through a contest, titled "Lifeline Facebook Application Challenge," that asks application developers to "provide actionable steps for Facebook users to increase their own personal preparedness and strengthen connections within their social networks for the sake of personal preparedness and community resilience," Kaiser Health News reports.
LifeCycle Pharma A/S has announced positive top-line results from a Phase 2 clinical trial involving 58 patients comparing LCP-Tacro™ tablets administered once-daily versus Prograf® (tacrolimus) capsules (Astellas Pharma) administered twice-daily in de novo liver transplant patients for one year.
CE Mark has been awarded to the new rotating thumbwheel deployment system for Cook Medical's Zilver PTX drug-eluting peripheral stent. The new system, which is now available for purchase in the UK, Ireland, Germany, Spain and Italy, provides simple deployment for the world's first and only approved drug-eluting stent for the superficial femoral artery (SFA).
› Verified 7 days ago
| Entity Name | Hattiesburg Gi Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730293234 PECOS PAC ID: 8921083288 Enrollment ID: O20040622000367 |
News Archive
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on December 29, 2009, it received a written notice from the listing qualifications staff of the NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on January 4, 2010 and that NASDAQ would initiate procedures to delist the Company's common stock.
The HHS Office of the Assistant Secretary for Preparedness and Response is trying to harness the power of social media to respond to public health emergencies through a contest, titled "Lifeline Facebook Application Challenge," that asks application developers to "provide actionable steps for Facebook users to increase their own personal preparedness and strengthen connections within their social networks for the sake of personal preparedness and community resilience," Kaiser Health News reports.
LifeCycle Pharma A/S has announced positive top-line results from a Phase 2 clinical trial involving 58 patients comparing LCP-Tacro™ tablets administered once-daily versus Prograf® (tacrolimus) capsules (Astellas Pharma) administered twice-daily in de novo liver transplant patients for one year.
CE Mark has been awarded to the new rotating thumbwheel deployment system for Cook Medical's Zilver PTX drug-eluting peripheral stent. The new system, which is now available for purchase in the UK, Ireland, Germany, Spain and Italy, provides simple deployment for the world's first and only approved drug-eluting stent for the superficial femoral artery (SFA).
› Verified 7 days ago
| Entity Name | Gastrointestinal Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093765604 PECOS PAC ID: 5294795241 Enrollment ID: O20041013001263 |
News Archive
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on December 29, 2009, it received a written notice from the listing qualifications staff of the NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on January 4, 2010 and that NASDAQ would initiate procedures to delist the Company's common stock.
The HHS Office of the Assistant Secretary for Preparedness and Response is trying to harness the power of social media to respond to public health emergencies through a contest, titled "Lifeline Facebook Application Challenge," that asks application developers to "provide actionable steps for Facebook users to increase their own personal preparedness and strengthen connections within their social networks for the sake of personal preparedness and community resilience," Kaiser Health News reports.
LifeCycle Pharma A/S has announced positive top-line results from a Phase 2 clinical trial involving 58 patients comparing LCP-Tacro™ tablets administered once-daily versus Prograf® (tacrolimus) capsules (Astellas Pharma) administered twice-daily in de novo liver transplant patients for one year.
CE Mark has been awarded to the new rotating thumbwheel deployment system for Cook Medical's Zilver PTX drug-eluting peripheral stent. The new system, which is now available for purchase in the UK, Ireland, Germany, Spain and Italy, provides simple deployment for the world's first and only approved drug-eluting stent for the superficial femoral artery (SFA).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen E Buckley, MD 100 Methodist Hospital Blvd, Hattiesburg, MS 39402-1295 Ph: (601) 268-5185 | Stephen E Buckley, MD 100 Methodist Hospital Blvd, Hattiesburg, MS 39402-1295 Ph: (601) 268-5185 |
News Archive
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on December 29, 2009, it received a written notice from the listing qualifications staff of the NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on January 4, 2010 and that NASDAQ would initiate procedures to delist the Company's common stock.
The HHS Office of the Assistant Secretary for Preparedness and Response is trying to harness the power of social media to respond to public health emergencies through a contest, titled "Lifeline Facebook Application Challenge," that asks application developers to "provide actionable steps for Facebook users to increase their own personal preparedness and strengthen connections within their social networks for the sake of personal preparedness and community resilience," Kaiser Health News reports.
LifeCycle Pharma A/S has announced positive top-line results from a Phase 2 clinical trial involving 58 patients comparing LCP-Tacro™ tablets administered once-daily versus Prograf® (tacrolimus) capsules (Astellas Pharma) administered twice-daily in de novo liver transplant patients for one year.
CE Mark has been awarded to the new rotating thumbwheel deployment system for Cook Medical's Zilver PTX drug-eluting peripheral stent. The new system, which is now available for purchase in the UK, Ireland, Germany, Spain and Italy, provides simple deployment for the world's first and only approved drug-eluting stent for the superficial femoral artery (SFA).
› Verified 7 days ago
Laurie Evans Douglas, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 301 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-261-1700 Fax: 601-288-8290 | |
Dr. Charles Ramsey Mccollum Iii, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5650 Fax: 601-579-5212 | |
Porter Hudson Glover, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5680 Fax: 601-268-5778 | |
Alex Gauthier, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5001 Hardy St, Hattiesburg, MS 39402 Phone: 601-268-8000 | |
Grettel Rodriguez Garcia, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 31 Woodstone Dr, Hattiesburg, MS 39402 Phone: 347-342-2441 | |
Ms. Manal Mohammad Abdur Rahman, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7 Medical Blvd, Hattiesburg, MS 39401 Phone: 601-296-2990 Fax: 601-296-2860 | |
Dr. Vashishtha Patel, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 5001 Hardy St, Hattiesburg, MS 39402 Phone: 704-733-7499 |